Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon E Elf

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Cell|July 21, 2021
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cellsDong Chen, Siyuan Xia, Rukang Zhang, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Molecular Cell|November 22, 2016
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor GrowthJun Fan, Ruiting Lin, Siyuan Xia, et al.
Nature|November 22, 2023
Trans-vaccenic acid reprograms CD8<sup>+</sup> T cells and anti-tumour immunityHao Fan, Siyuan Xia, Junhong Xiang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Cell|July 21, 2021
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cellsDong Chen, Siyuan Xia, Rukang Zhang, et al.
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Blood|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasmsNicole S Arellano, William L Heaton, Mirielle C Nauman, et al.
Molecular Cell|November 22, 2016
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor GrowthJun Fan, Ruiting Lin, Siyuan Xia, et al.
Nature|November 22, 2023
Trans-vaccenic acid reprograms CD8<sup>+</sup> T cells and anti-tumour immunityHao Fan, Siyuan Xia, Junhong Xiang, et al.
Pageof 2